Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - CCCC

Basics
Company: C4 Therapeutics, Inc.
IPO Date: October 2, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $224.47M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.54 | 3.81%
Avg Daily Range (30 D): $0.10 | 2.72%
Avg Daily Range (90 D): $0.18 | 3.80%
Institutional Daily Volume
Avg Daily Volume: 1.37M
Avg Daily Volume (30 D): .72M
Avg Daily Volume (90 D): .83M
Trade Size
Avg Trade Size (Sh.): 140
Avg Trade Size (Sh.) (30 D): 120
Avg Trade Size (Sh.) (90 D): 109
Institutional Trades
Total Inst.Trades: 1,019
Avg Inst. Trade: $1.93M
Avg Inst. Trade (30 D): $2.88M
Avg Inst. Trade (90 D): $2.21M
Avg Inst. Trade Volume: .19M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.19M
Avg Closing Trade (30 D): $1.2M
Avg Closing Trade (90 D): $1.14M
Avg Closing Volume: 176.23K
   
News
Jan 29, 2025 @ 6:00 PM
BRAF Inhibitors Market to Register Incremental Gro...
Source: Delveinsight
Jan 9, 2025 @ 3:53 PM
NUT Midline Carcinoma Treatment Market Research Re...
Source: Researchandmarkets.Com
Dec 8, 2024 @ 5:30 PM
C4 Therapeutics Presents Cemsidomide Phase 1 Data ...
Source: N/A
Nov 20, 2024 @ 12:00 PM
C4 Therapeutics Appoints Accomplished Oncology Exe...
Source: N/A
Sep 13, 2024 @ 2:00 PM
C4 Therapeutics Presents Monotherapy Data Demonstr...
Source: N/A
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-1.7 $-.35 $-.26
Diluted EPS $-1.7 $-.35 $-.26
Revenue $ 33.67M $ 15.36M $ 12.01M
Gross Profit $ $ $
Net Income / Loss $ -105.5M $ -24.67M $ -17.72M
Operating Income / Loss $ -119.33M $ -28.24M $ -21.44M
Cost of Revenue $ $ $
Net Cash Flow $ -1.33M $ -13.47M $ -16.55M
PE Ratio